Benchmarking and Transparency: Incentives for the Pharmaceutical Industry’s Corporate Social Responsibility
Authors:
- 16 February 2010
- journal article
- Published by Springer Nature in Journal of Business Ethics
- Vol. 95 (4) , 641-658
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Strengthening corporate social responsibility in the pharmaceutical industryJournal of Medical Marketing: Device, Diagnostic and Pharmaceutical Marketing, 2008
- The Social Responsibility of Business Is to Increase Its Profits2007
- “AIDS is Not a Business”: A Study in Global Corporate Responsibility – Securing Access to Low-cost HIV MedicationsJournal of Business Ethics, 2006
- Corporate Social Performance and Stock Returns: UK Evidence from Disaggregate MeasuresFinancial Management, 2006
- Managing ethical standards: When rhetoric meets realityDevelopment in Practice, 2005
- Corporate social responsibility – a PR invention?Corporate Communications: An International Journal, 2001
- ‘We Have the Facts’—How Business Claims Legitimacy in the Environmental DebateEnvironment and Planning A: Economy and Space, 1999
- Image repair discourse and crisis communicationPublic Relations Review, 1997
- How corporate social responsibility pays offLong Range Planning, 1996
- The effectiveness of corporate communicative responses to accusations of unethical behaviorJournal of Business Ethics, 1995